1. Home
  2. VTGN

as of 02-25-2026 11:54am EST

$0.56
$0.00
-0.41%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Founded: 1998 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 21.8M IPO Year: 2014
Target Price: $0.90 AVG Volume (30 days): 975.0K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.46 EPS Growth: -9.87
52 Week Low/High: $0.43 - $5.14 Next Earning Date: 05-25-2026
Revenue: N/A Revenue Growth: -120.47%
Revenue Growth (this year): 93.93% Revenue Growth (next year): 243.88%
P/E Ratio: -0.38 Index: N/A
Free Cash Flow: -42297400.0 FCF Growth: N/A

AI-Powered VTGN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 19 hours ago

AI Recommendation

hold
Model Accuracy: 73.62%
73.62%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: